Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 5.06
-0.09 (-1.75%)
At close: May 21, 2026
SHA:688373 Market Cap
SHA:688373 has a market cap or net worth of 3.32 billion as of May 21, 2026. Its market cap has decreased by -12.52% in one year.
Market Cap
3.32B
Enterprise Value
3.27B
Revenue
150.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.06
Market Cap Chart
Since August 5, 2022, SHA:688373's market cap has decreased from 7.13B to 3.32B, a decrease of -53.42%. That is a compound annual growth rate of -18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 3.32B | -16.15% |
| Dec 31, 2025 | 3.96B | 22.34% |
| Dec 31, 2024 | 3.24B | -24.35% |
| Dec 29, 2023 | 4.28B | -26.30% |
| Dec 30, 2022 | 5.81B | -18.57% |
| Aug 5, 2022 | 7.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Well Pharmaceutical Group | 3.65B |
| Hunan Hansen Pharmaceutical | 3.60B |
| Zhejiang Cheng Yi Pharmaceutical | 3.60B |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 3.58B |
| Huaren Pharmaceutical | 3.56B |
| Tibet AIM Pharm. | 3.56B |
| Harbin Medisan Pharmaceutical | 3.49B |
| Tuoxin Pharmaceutical Group | 3.44B |